Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Impairments in Emotion Recognition and Risk-Taking Behavior After Isolated, Cerebellar Stroke.

van den Berg NS, Huitema RB, Spikman JM, Luijckx GJ, de Haan EHF.

Cerebellum. 2020 Feb 27. doi: 10.1007/s12311-020-01121-x. [Epub ahead of print]

PMID:
32108305
2.

Centralising acute stroke care within clinical practice in the Netherlands: lower bounds of the causal impact.

Freriks RD, Mierau JO, Buskens E, Pizzo E, Luijckx GJ, van der Zee DJ, Lahr MMH.

BMC Health Serv Res. 2020 Feb 10;20(1):103. doi: 10.1186/s12913-020-4959-3.

3.

Optimising acute stroke care organisation: a simulation study to assess the potential to increase intravenous thrombolysis rates and patient gains.

Lahr MMH, van der Zee DJ, Luijckx GJ, Buskens E.

BMJ Open. 2020 Jan 20;10(1):e032780. doi: 10.1136/bmjopen-2019-032780.

4.

The Dutch Parelsnoer Institute Cerebrovascular Disease Initiative: a retrospective study of the effects of integrating clinical care and research on costs and quality of care in patients with ischaemic stroke.

Mensing LA, Kappelle J, Buijs JE, Luijckx GJ, Koffijberg H, Zielhuis GA, Ruigrok YM.

BMJ Open. 2019 Aug 27;9(8):e028290. doi: 10.1136/bmjopen-2018-028290.

5.

Effects of Head and Neck Positions on Blood Flow in the Vertebral, Internal Carotid, and Intracranial Arteries: A Systematic Review.

Kranenburg HAR, Tyer R, Schmitt M, Luijckx GJ, van der Schans C, Hutting N, Kerry R.

J Orthop Sports Phys Ther. 2019 Oct;49(10):688-697. doi: 10.2519/jospt.2019.8578. Epub 2019 Jul 5.

PMID:
31276624
6.

Clinical relevance of short-term follow-up of unruptured intracranial aneurysms.

Molenberg R, Aalbers MW, Metzemaekers JDM, Mazuri A, Luijckx GJ, Groen RJM, Uyttenboogaart M, van Dijk JMC.

Neurosurg Focus. 2019 Jul 1;47(1):E7. doi: 10.3171/2019.4.FOCUS1995.

PMID:
31261130
7.

Corrigendum to "Adverse events associated with the use of cervical spine manipulation or mobilization and patient characteristics: A systematic review" <[Musculoskelet. Sci. Pract. 28C (2017) 32-38]>.

Kranenburg HA, Schmitt MA, Puentedura EJ, Luijckx GJ, van der Schans CP.

Musculoskelet Sci Pract. 2018 Aug;36:96. doi: 10.1016/j.msksp.2018.05.002. Epub 2018 May 18. No abstract available.

PMID:
29786529
8.

Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome.

van den Berg MP, Almomani R, Biaggioni I, van Faassen M, van der Harst P, SilljƩ HHW, Mateo Leach I, Hemmelder MH, Navis G, Luijckx GJ, de Brouwer APM, Venselaar H, Verbeek MM, van der Zwaag PA, Jongbloed JDH, van Tintelen JP, Wevers RA, Kema IP.

Circ Res. 2018 Mar 16;122(6):846-854. doi: 10.1161/CIRCRESAHA.117.311949. Epub 2018 Jan 17.

9.

European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke.

Kobayashi A, Czlonkowska A, Ford GA, Fonseca AC, Luijckx GJ, Korv J, de la Ossa NP, Price C, Russell D, Tsiskaridze A, Messmer-Wullen M, De Keyser J.

Eur J Neurol. 2018 Mar;25(3):425-433. doi: 10.1111/ene.13539. Epub 2018 Jan 12. Review. Erratum in: Eur J Neurol. 2018 Oct;25(10):1303.

PMID:
29218822
10.

Response to - Adverse events associated with the use of cervical spine manipulation or mobilization and patient characteristics: A systematic review.

Kranenburg HA, Schmitt MA, Puentedura EJ, Luijckx GJR, Van der Schans CP.

Musculoskelet Sci Pract. 2017 Aug;30:e95. doi: 10.1016/j.msksp.2017.05.008. Epub 2017 May 26. No abstract available.

PMID:
28583771
11.

Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype.

Hauer AJ, Ruigrok YM, Algra A, van Dijk EJ, Koudstaal PJ, Luijckx GJ, Nederkoorn PJ, van Oostenbrugge RJ, Visser MC, Wermer MJ, Kappelle LJ, Klijn CJM; Dutch Parelsnoer Instituteā€Cerebrovascular Accident Study Group.

J Am Heart Assoc. 2017 May 8;6(5). pii: e005090. doi: 10.1161/JAHA.116.005090.

12.

Adverse events associated with the use of cervical spine manipulation or mobilization and patient characteristics: A systematic review.

Kranenburg HA, Schmitt MA, Puentedura EJ, Luijckx GJ, van der Schans CP.

Musculoskelet Sci Pract. 2017 Apr;28:32-38. doi: 10.1016/j.msksp.2017.01.008. Epub 2017 Jan 23. Review. Erratum in: Musculoskelet Sci Pract. 2018 May 18;:.

PMID:
28171776
13.

Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

BMC Med Res Methodol. 2017 Jan 10;17(1):5. doi: 10.1186/s12874-016-0275-3.

14.

Intra-arterial Treatment for Basilar Artery Occlusion-Reply.

van Houwelingen RC, Luijckx GJ, Uyttenboogaart M.

JAMA Neurol. 2017 Jan 1;74(1):130-131. doi: 10.1001/jamaneurol.2016.4870. No abstract available.

PMID:
27893877
15.

Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure.

Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M, van Laar PJ, van Deursen VM, van der Meer P, van Veldhuisen DJ, Voors AA, Luijckx GJ.

Eur J Heart Fail. 2017 Feb;19(2):261-268. doi: 10.1002/ejhf.660. Epub 2016 Nov 14.

16.

COOLIST (Cooling for Ischemic Stroke Trial): A Multicenter, Open, Randomized, Phase II, Clinical Trial.

Geurts M, Petersson J, Brizzi M, Olsson-Hau S, Luijckx GJ, Algra A, Dippel DW, Kappelle LJ, van der Worp HB.

Stroke. 2017 Jan;48(1):219-221. doi: 10.1161/STROKEAHA.116.014757. Epub 2016 Nov 17.

PMID:
27856954
17.

Simulation modelling to assess prehospital thrombolysis.

Lahr MMH, van der Zee DJ, Luijckx GJ, Uyttenboogaart M, Buskens E.

Lancet Neurol. 2016 Dec;15(13):1305-1306. doi: 10.1016/S1474-4422(16)30288-5. No abstract available.

PMID:
27839643
18.

Safety and Outcome of Intra-Arterial Treatment for Basilar Artery Occlusion.

van Houwelingen RC, Luijckx GJ, Mazuri A, Bokkers RP, Eshghi OS, Uyttenboogaart M.

JAMA Neurol. 2016 Oct 1;73(10):1225-1230. doi: 10.1001/jamaneurol.2016.1408.

PMID:
27532477
19.

Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes?

Miedema I, Luijckx GJ, Brouns R, De Keyser J, Uyttenboogaart M.

BMC Neurol. 2016 Jul 15;16:104. doi: 10.1186/s12883-016-0617-0.

20.

Prediction of outcome after subarachnoid hemorrhage: timing of clinical assessment.

van Donkelaar CE, Bakker NA, Veeger NJ, Uyttenboogaart M, Metzemaekers JD, Eshghi O, Mazuri A, Foumani M, Luijckx GJ, Groen RJ, van Dijk JM.

J Neurosurg. 2017 Jan;126(1):52-59. doi: 10.3171/2016.1.JNS152136. Epub 2016 Apr 1.

PMID:
27035175
21.

Reply to Verhaeghe et al.

Akkerman OW, van Hateren K, Koster RA, Luijckx GJ, van der Werf TS, Alffenaar JW.

Clin Infect Dis. 2016 Jul 1;63(1):146-7. doi: 10.1093/cid/ciw165. Epub 2016 Mar 29. No abstract available.

PMID:
27025830
22.

Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis.

Akkerman OW, Odish OF, Bolhuis MS, de Lange WC, Kremer HP, Luijckx GJ, van der Werf TS, Alffenaar JW.

Clin Infect Dis. 2016 Feb 15;62(4):523-4. doi: 10.1093/cid/civ921. Epub 2015 Nov 3. No abstract available.

PMID:
26534926
23.

The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.

Buijs JE, Uyttenboogaart M, Brouns R, de Keyser J, Kamphuisen PW, Luijckx GJ.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):312-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.035. Epub 2015 Oct 30.

PMID:
26527412
24.

Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.

van Donkelaar CE, Bakker NA, Veeger NJ, Uyttenboogaart M, Metzemaekers JD, Luijckx GJ, Groen RJ, van Dijk JM.

Stroke. 2015 Aug;46(8):2100-6. doi: 10.1161/STROKEAHA.115.010037. Epub 2015 Jun 11.

PMID:
26069261
25.

Recurrence Rates After Surgical or Endovascular Treatment of Spinal Dural Arteriovenous Fistulas: A Meta-analysis.

Bakker NA, Uyttenboogaart M, Luijckx GJ, Eshghi OS, Mazuri A, Metzemaekers JD, Groen RJ, Van Dijk JM.

Neurosurgery. 2015 Jul;77(1):137-44; discussion 144. doi: 10.1227/NEU.0000000000000727.

PMID:
25790071
26.

Clinical features and prognosis of intracranial artery dissection.

Sikkema T, Uyttenboogaart M, van Dijk JM, Groen RJ, Metzemaekers JD, Eshghi O, Mazuri A, Bakker NA, Luijckx GJ.

Neurosurgery. 2015 Jun;76(6):663-70; discussion 670-1. doi: 10.1227/NEU.0000000000000696.

PMID:
25714522
27.

The Dutch String-of-Pearls Stroke Study: protocol of a large prospective multicenter genetic cohort study.

Nederkoorn PJ, van Dijk EJ, Koudstaal PJ, Luijckx GJ, van Oostenbrugge RJ, Visser MC, Wermer MJ, Ruigrok YM, Algra A, Kappelle LJ; Dutch String-of-Pearls Stroke Study-Group.

Int J Stroke. 2015 Jan;10(1):120-2. doi: 10.1111/ijs.12359. Epub 2014 Aug 17.

PMID:
25131301
28.

Improving acute stroke services in the Netherlands.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

BMJ. 2014 Jun 24;348:g3957. doi: 10.1136/bmj.g3957. No abstract available.

PMID:
24962694
29.

Intracranial artery dissection.

Sikkema T, Uyttenboogaart M, Eshghi O, De Keyser J, Brouns R, van Dijk JM, Luijckx GJ.

Eur J Neurol. 2014 Jun;21(6):820-6. doi: 10.1111/ene.12384. Epub 2014 Feb 22. Review.

PMID:
24824740
30.

Prehospital factors determining regional variation in thrombolytic therapy in acute ischemic stroke.

Lahr MM, Vroomen PC, Luijckx GJ, van der Zee DJ, de Vos R, Buskens E.

Int J Stroke. 2014 Oct;9 Suppl A100:31-5. doi: 10.1111/ijs.12236. Epub 2013 Dec 23.

PMID:
24373584
31.

Appreciation of CT-negative, lumbar puncture-positive subarachnoid haemorrhage: risk factors for presence of aneurysms and diagnostic yield of imaging.

Bakker NA, Groen RJ, Foumani M, Uyttenboogaart M, Eshghi OS, Metzemaekers JD, Luijckx GJ, Van Dijk JM.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):885-8. doi: 10.1136/jnnp-2013-305955. Epub 2013 Dec 19.

PMID:
24357683
32.

Nuclear imaging in proliferative angiopathy.

Kolderman SE, Noordzij W, van Dijk JM, Luijckx GJ.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):810. doi: 10.1007/s00259-013-2645-y. Epub 2013 Dec 3. No abstract available.

PMID:
24297505
33.

Thrombolysis in acute ischemic stroke: a simulation study to improve pre- and in-hospital delays in community hospitals.

Lahr MM, van der Zee DJ, Vroomen PC, Luijckx GJ, Buskens E.

PLoS One. 2013 Nov 18;8(11):e79049. doi: 10.1371/journal.pone.0079049. eCollection 2013.

34.

Repeat digital subtraction angiography after a negative baseline assessment in nonperimesencephalic subarachnoid hemorrhage: a pooled data meta-analysis.

Bakker NA, Groen RJ, Foumani M, Uyttenboogaart M, Eshghi OS, Metzemaekers JD, Lammers N, Luijckx GJ, Van Dijk JM.

J Neurosurg. 2014 Jan;120(1):99-103. doi: 10.3171/2013.9.JNS131337. Epub 2013 Oct 25. Review.

PMID:
24160474
35.

Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.

Majeed A, Meijer K, Larrazabal R, Arnberg F, Luijckx GJ, Roberts RS, Schulman S.

Thromb Haemost. 2014 Feb;111(2):233-9. doi: 10.1160/TH13-07-0536. Epub 2013 Oct 24.

PMID:
24154891
36.

Teaching neuroimages: FDG-PET imaging in primary diffuse leptomeningeal gliomatosis.

Weijenberg A, van Dijk JM, Pruim J, Luijckx GJ.

Neurology. 2013 Oct 15;81(16):e119-20. doi: 10.1212/WNL.0b013e3182a840db. No abstract available.

PMID:
24127193
37.

A simulation-based approach for improving utilization of thrombolysis in acute brain infarction.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

Med Care. 2013 Dec;51(12):1101-5. doi: 10.1097/MLR.0b013e3182a3e505.

PMID:
23938599
38.

Letter by Plas et al regarding article, "smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke".

Plas GJ, Uyttenboogaart M, Luijckx GJ.

Stroke. 2013 May;44(5):e58. doi: 10.1161/STROKEAHA.113.001158. Epub 2013 Apr 4. No abstract available.

PMID:
23559266
39.

Co-morbidities in heart failure.

van Deursen VM, Damman K, van der Meer P, Wijkstra PJ, Luijckx GJ, van Beek A, van Veldhuisen DJ, Voors AA.

Heart Fail Rev. 2014 Mar;19(2):163-72. doi: 10.1007/s10741-012-9370-7. Review.

PMID:
23266884
40.

Bleeding risk with ischemic stroke therapy.

Miedema I, Luijckx GJ, Uyttenboogaart M.

JAMA. 2012 Oct 3;308(13):1318-9; author reply 1319-20. doi: 10.1001/2012.jama.11664. No abstract available.

PMID:
23032535
41.

Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke.

Miedema I, Uyttenboogaart M, Luijckx GJ.

Expert Rev Neurother. 2012 Aug;12(8):907-10.

PMID:
23002934
42.

The sNIHSS-4 predicts outcome in right and left anterior circulation strokes.

De Raedt S, Brouns R, De Smedt A, Aries MJ, Uyttenboogaart M, Luijckx GJ, De Keyser J.

Clin Neurol Neurosurg. 2013 Jun;115(6):729-31. doi: 10.1016/j.clineuro.2012.08.026. Epub 2012 Sep 8.

PMID:
22964346
43.

The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Lahr MM, Luijckx GJ, Vroomen PC, van der Zee DJ, Buskens E.

J Neurol. 2013 Apr;260(4):960-8. doi: 10.1007/s00415-012-6647-7. Epub 2012 Aug 23. Review.

PMID:
22915092
45.

Lack of association between serum uric acid levels and outcome in acute ischemic stroke.

Miedema I, Uyttenboogaart M, Koch M, Kremer B, de Keyser J, Luijckx GJ.

J Neurol Sci. 2012 Aug 15;319(1-2):51-5. doi: 10.1016/j.jns.2012.05.019. Epub 2012 May 26.

PMID:
22633441
46.

Acute stroke management in patients taking dabigatran.

Brouns R, Van Hooff RJ, De Smedt A, Moens M, De Raedt S, Uyttenboogaart M, Luijckx GJ, Jochmans K, De Keyser J.

CNS Neurosci Ther. 2012 Aug;18(8):616-22. doi: 10.1111/j.1755-5949.2012.00329.x. Epub 2012 Apr 25. Review.

47.

Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting.

Lahr MM, Luijckx GJ, Vroomen PC, van der Zee DJ, Buskens E.

Stroke. 2012 May;43(5):1336-40. doi: 10.1161/STROKEAHA.111.641795. Epub 2012 Mar 16.

PMID:
22426467
48.

Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis.

Miedema I, Luijckx GJ, De Keyser J, Koch M, Uyttenboogaart M.

J Neurol Neurosurg Psychiatry. 2012 May;83(5):537-40. doi: 10.1136/jnnp-2011-301794. Epub 2012 Feb 29. Review.

PMID:
22378917
49.

Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies.

Cordenier A, De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Luijckx GJ, De Keyser J.

Acta Neurol Belg. 2011 Dec;111(4):261-7. Review.

PMID:
22368964
50.

Prior anticoagulant therapy, subtherapeutic international normalized ratio and thrombolytic therapy in acute ischemic stroke.

Miedema I, Gosselt A, de Keyser J, Koopman K, Kremer B, Luijckx GJ, Uyttenboogaart M.

Int J Stroke. 2011 Dec;6(6):568-9. doi: 10.1111/j.1747-4949.2011.00669.x. No abstract available.

PMID:
22111806

Supplemental Content

Loading ...
Support Center